Ten-year results of chemoradiation for anal cancer: focus on late morbidity.

Int J Radiat Oncol Biol Phys

Central California Cancer Research Group, Fresno, USA.

Published: January 1996

Purpose: To evaluate (a) long-term survival and (b) the incidence and nature of long-term morbidity/ mortality related to chemoradiation using the anal cancer experience.

Methods And Materials: From January 1979 to April 1987,34 consecutive patients with Stage I (5 patients), II (15 patients), and II (14 patients) cancers of the anal canal were treated definitively with a chemoradiation regimen combining 41.4 Gy pelvic radiotherapy with two concurrent cycles of 5-fluorouracil and mitomycin C. Cumulative actuarial survival was calculated at 10 years and long-term morbidity was categorized per RTOG/EORTC late toxicity criteria. Specific criteria to grade anal toxicity were devised.

Results: Cumulative survival for all 34 patients was 92% at 5 years and 85% at 10 years. The most frequent late toxicity was chronic diarrhea in 17 (50%) patients. Five patients (15%) had Grade 3 or 4 late toxicities. Sexual dysfunction was present in 2 of 26 evaluable patients (7%).

Conclusions: Excellent long-term survival and colostomy-free survival is possible for anal cancer patients treated definitively by chemoradiation. Late effects do not appear to be frequent or intense enough to deter the use of chemoradiation in anal cancer. The biologically expected increase in long-term toxicity when combining radiotherapy and chemotherapy is not substantiated by the results of this study.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0360-3016(95)00223-5DOI Listing

Publication Analysis

Top Keywords

anal cancer
16
chemoradiation anal
12
patients patients
12
patients
9
long-term survival
8
treated definitively
8
definitively chemoradiation
8
late toxicity
8
anal
6
late
5

Similar Publications

A Triple-Responsive and Dual-NIR Emissive Fluorescence Probe for Precise Cancer Imaging and Therapy by Activating Pyroptosis Pathway.

Anal Chem

January 2025

Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Department of Pharmacy and Pharmacology, Hengyang Medical School, University of South China, Hengyang 421002, China.

Revealing changes in the tumor microenvironment is crucial for understanding cancer and developing sensitive methods for precise cancer imaging and diagnosis. Intracellular hydrogen peroxide (HO) and microenvironmental factors (e.g.

View Article and Find Full Text PDF

Rats responded under a concurrent-chains procedure wherein reinforcement magnitude was varied within sessions and oxycodone's effects on sensitivity to magnitude were evaluated in two experiments. In Experiment 1, the alternative providing the larger magnitude was signaled and effects of acute (0.1-1.

View Article and Find Full Text PDF

A Bacteria-Responsive Multifunctional Nanohydrogel for Recognition of Bacterial Infections and Activable Four-in-One Antibacterial Therapy.

Anal Chem

January 2025

Key Laboratory of Optic-electric Sensing and Analytical Chemistry for Life Science, Ministry of Education, College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.

Bacterial infections have long been a formidable challenge in global public health, further compounded by the emergence of drug-resistant bacteria resulting from the overuse and misuse of antibiotics. Intelligent antibacterial strategies are garnering escalating attention and concern due to their ability to accurately recognize bacterial infections, efficiently eliminate pathogens, and timely monitor infection end points in order to mitigate the adverse effects of excessive treatment on normal tissues. Hence, in this study, we developed a multifunctional antibacterial nanohydrogel that exhibited bacteria-triggered fluorescence activity, serving as a fluorescent indicator for bacterial infections.

View Article and Find Full Text PDF

Background: Human papillomavirus (HPV) is associated with an increased risk for a variety of squamous cell carcinomas (SCCs) in the general population. The risk for subsequent SCCs in BMT survivors that are potentially related to HPV (cervical, oropharyngeal, vulvar, vaginal, anal, and penile cancer; HPV-related SCCs) remains unknown.

Methods: We determined the risk of HPV-related SCCs in 7,936 2 y-survivors of autologous or allogeneic BMT performed between 1974 and 2014 and identified the role of demographic and clinical factors associated with HPV-related SCCs using proportional subdistribution hazards model for competing risks.

View Article and Find Full Text PDF

Background Human papillomavirus (HPV)-associated cancers are a global concern, particularly for sexual minority men (SMM). Understanding awareness and the determinants of these beliefs is crucial for developing educational programs to reduce HPV-associated cancers. This study explored awareness and determinants of beliefs about HPV's carcinogenicity among SMM living with and without HIV in Nigeria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!